{"result": "```json\n{\n    \"title\": \"Gilles De La Tourette Syndrome and Associated Treatments\",\n    \"summary\": \"This community focuses on Gilles De La Tourette Syndrome (GTS) and its associated treatments, including Clonidine and Gabapentin. The relationships among these entities highlight the complex interplay between symptoms, treatments, and potential side effects, emphasizing the need for careful management in clinical settings.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the significant health implications and potential side effects associated with the treatments for Gilles De La Tourette Syndrome.\",\n    \"findings\": [\n        {\n            \"summary\": \"Clonidine's role in managing GTS symptoms\",\n            \"explanation\": \"Clonidine is a key medication used to palliate symptoms of Gilles De La Tourette Syndrome. It is effective in managing symptoms such as hyperkinesis and aggression, which are common in GTS patients. However, Clonidine is also associated with several side effects, including abdominal pain, anxiety, and orthostatic hypotension, which necessitate careful monitoring during treatment. The relationship between Clonidine and GTS underscores the importance of balancing symptom management with the potential for adverse reactions [Data: Entities (23); Relationships (67, 54, 55, 60, 63, +more)].\"\n        },\n        {\n            \"summary\": \"Gabapentin's application in GTS treatment\",\n            \"explanation\": \"Gabapentin is utilized to alleviate symptoms associated with Restless Legs Syndrome, which can co-occur with Gilles De La Tourette Syndrome. While it is effective in managing discomfort, Gabapentin is linked to various side effects, including abdominal pain and aggression. The relationship between Gabapentin and GTS highlights the need for a comprehensive approach to treatment that considers both the benefits and risks associated with its use [Data: Entities (29); Relationships (28, 69, 70, 68, +more)].\"\n        },\n        {\n            \"summary\": \"Diverse symptoms associated with GTS\",\n            \"explanation\": \"Gilles De La Tourette Syndrome presents a range of symptoms, including tics, hyperkinesis, and language disorders. These symptoms can significantly impact the quality of life for affected individuals. Understanding the diverse manifestations of GTS is crucial for developing effective treatment strategies that address both the neurological and psychological aspects of the disorder [Data: Entities (186); Relationships (35, 43, 491, 493, 494, +more)].\"\n        },\n        {\n            \"summary\": \"Potential side effects of GTS treatments\",\n            \"explanation\": \"The treatments for Gilles De La Tourette Syndrome, including Clonidine and Gabapentin, are associated with various side effects that can complicate patient management. Common side effects include aggression, abdominal pain, and anxiety. Awareness of these potential adverse reactions is essential for healthcare providers to ensure patient safety and optimize treatment outcomes [Data: Entities (31, 30); Relationships (55, 69, 70, 60, +more)].\"\n        },\n        {\n            \"summary\": \"Interconnectedness of GTS and other neurological disorders\",\n            \"explanation\": \"Gilles De La Tourette Syndrome shares symptoms with other neurological disorders, such as Huntington Disease. This interconnectedness emphasizes the need for differential diagnosis and tailored treatment plans that consider the unique presentation of each disorder. Understanding these relationships can aid in providing comprehensive care for patients with overlapping symptoms [Data: Entities (186, 193); Relationships (491, 492, +more)].\"\n        }\n    ]\n}\n```", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n----Reports-----\nid,full_content\n22,\"# Medical Conditions and Their Treatments\n\nThis community encompasses various medical conditions, their associated symptoms, and the treatments used to manage them. Key entities include asthenia, anorexia, and angina pectoris, which are linked to multiple medical treatments and conditions, highlighting the complex interplay between symptoms and pharmacological interventions.\n\n## Asthenia as a common symptom\n\nAsthenia is a prevalent medical condition characterized by a significant lack of energy and strength. It is often associated with various illnesses, including stomach cancer and osteoporosis, and can arise as a side effect of multiple treatments such as Fluorouracil and Doxorubicin. The relationship between asthenia and these conditions underscores its importance in clinical settings, as it can significantly affect patient quality of life and treatment outcomes. [Data: Entities (138), Relationships (373, 370, 375, 372)]\n\n## Anorexia linked to serious medical conditions\n\nAnorexia is a multifaceted condition that can result in significant weight loss and nutritional deficiencies. It is associated with various cancers, including stomach cancer and vaginal cancer, and can also be a side effect of treatments like Fluorouracil and microtubule inhibitors. The presence of anorexia in patients with serious medical conditions highlights the need for comprehensive management strategies to address both the psychological and physical aspects of this symptom. [Data: Entities (145), Relationships (388, 386, 390, 385, 389)]\n\n## Angina Pectoris as a critical health concern\n\nAngina Pectoris is a significant medical condition characterized by chest pain due to reduced blood flow to the heart. It is often associated with hypertension and can arise as a side effect of various medications, including Metformin and Guanethidine. The relationship between angina pectoris and hypertension emphasizes the importance of monitoring cardiovascular health in patients receiving these treatments, as it can lead to severe complications if not managed properly. [Data: Entities (43), Relationships (132, 81, 133)]\n\n## The role of microtubule inhibitors in cancer treatment\n\nMicrotubule inhibitors are a pharmacologic class used primarily in the treatment of stomach cancer. While effective, they are associated with several side effects, including asthenia and abdominal pain. The use of these inhibitors highlights the need for careful patient monitoring and management of side effects to ensure optimal treatment outcomes and patient safety. [Data: Entities (351), Relationships (681, 146)]\n\n## Serious side effects associated with Guanethidine\n\nGuanethidine is primarily used to treat hypertension but is linked to several serious side effects, including abdominal pain, angina pectoris, and even anaphylactic shock. The potential for such severe reactions necessitates careful consideration when prescribing this medication, particularly in patients with pre-existing health conditions. [Data: Entities (483), Relationships (818, 150, 100)]\"\n20,\"# Doxorubicin and Prostate Cancer Treatment Community\n\nThis community centers around Doxorubicin, a key compound used in the treatment of various cancers, including Prostate Cancer. The relationships among the entities highlight the interconnectedness of cancer symptoms, treatments, and side effects, particularly focusing on the implications of Doxorubicin and its associated side effects.\n\n## Doxorubicin's role in cancer treatment\n\nDoxorubicin is a vital compound classified as a topoisomerase inhibitor, primarily utilized in treating various cancers, including Prostate Cancer, Vaginal Cancer, and Sarcoma. Its effectiveness in managing these malignancies underscores its importance in oncology. However, the compound is also associated with serious side effects, such as abdominal distension and agranulocytosis, which can complicate treatment outcomes. The relationships between Doxorubicin and the cancers it treats highlight its central role in this community, making it a focal point for understanding cancer therapies and their implications. [Data: Entities (348); Relationships (687, 678, 689, 688)]\n\n## Prostate Cancer and its symptoms\n\nProstate Cancer is a significant entity within this community, characterized by the uncontrolled growth of prostate cells. It presents various symptoms, including abdominal pain, fatigue, and feminization, which can severely impact patients' quality of life. The relationships between Prostate Cancer and its symptoms indicate a complex interplay that necessitates careful management. The treatment of Prostate Cancer often involves multiple medications, including Doxorubicin, which can lead to various side effects that further complicate the clinical picture. [Data: Entities (101); Relationships (271, 262, 280, 230)]\n\n## Side effects associated with Doxorubicin\n\nDoxorubicin is linked to several serious side effects, including abdominal pain, lactic acidosis, and arrhythmia. These side effects can significantly affect patient management and treatment adherence. For instance, abdominal pain is a common side effect of Doxorubicin, which can also be exacerbated by other medications used in cancer treatment. The potential for serious side effects necessitates close monitoring of patients undergoing treatment with Doxorubicin, highlighting the importance of understanding these relationships in the context of cancer therapy. [Data: Entities (348, 210, 465); Relationships (149, 375, 690)]\n\n## Interconnectedness of cancer treatments\n\nThe community illustrates the interconnectedness of various cancer treatments and their side effects. For example, medications like Fentanyl, Esomeprazole, and Hydrocortisone are used to palliate symptoms of Prostate Cancer, but they also have their own side effects, which can overlap with those of Doxorubicin. This interconnectedness emphasizes the complexity of cancer treatment regimens and the need for a comprehensive approach to patient care that considers all potential interactions and side effects. [Data: Entities (120, 121, 123); Relationships (271, 272, 274)]\n\n## The significance of symptom management\n\nEffective symptom management is crucial in the treatment of Prostate Cancer and other malignancies. Symptoms such as abdominal pain, fatigue, and nausea can significantly impact a patient's quality of life and treatment outcomes. The relationships between these symptoms and the various treatments highlight the importance of addressing not only the cancer itself but also the associated symptoms to improve overall patient well-being. This underscores the need for a holistic approach in cancer care that prioritizes symptom management alongside direct cancer treatment. [Data: Entities (44, 105, 101); Relationships (261, 255, 256)]\"\n19,\"# Cancer Treatment and Side Effects Community\n\nThis community encompasses various compounds used in cancer treatment and their associated side effects. Key entities include Fluorouracil, Isradipine, Raloxifene, Metoclopramide, and Nicotine, which are interconnected through their therapeutic applications and the side effects they may cause.\n\n## Fluorouracil's role in cancer treatment\n\nFluorouracil is a significant compound in the treatment of various cancers, including stomach, vaginal, and urinary bladder cancers. Its effectiveness in managing these conditions highlights its importance in oncology. However, Fluorouracil is also associated with severe side effects such as anaphylactic shock, alopecia, and congenital anomalies, which necessitate careful monitoring during treatment. The compound's dual role as both a therapeutic agent and a source of serious side effects underscores its critical position in cancer therapy [Data: Entities (344), Relationships (683, 674, 684, 98, 453, +more)].\n\n## Isradipine's application in hypertension\n\nIsradipine is primarily used to treat hypertension, indicating its role in managing blood pressure. However, it is also linked to side effects such as anxiety and atrial fibrillation, which can complicate treatment regimens. The relationship between Isradipine and hypertension is direct, but the potential adverse effects highlight the need for careful patient assessment and management to mitigate risks associated with its use [Data: Entities (484), Relationships (819, 376, 378, +more)].\n\n## Raloxifene's use in osteoporosis\n\nRaloxifene is utilized in the treatment of osteoporosis, a condition that weakens bones and increases fracture risk. While effective, Raloxifene is associated with side effects such as abdominal pain, arthralgia, and angioedema. The compound's therapeutic benefits must be weighed against these potential adverse effects, emphasizing the importance of patient education and monitoring during treatment [Data: Entities (452), Relationships (790, 399, 128, 115, +more)].\n\n## Metoclopramide's role in palliative care\n\nMetoclopramide is used to palliate symptoms of prostate cancer, providing relief to patients experiencing discomfort. However, it is associated with side effects such as anxiety and agranulocytosis, which can pose significant health risks. The dual nature of Metoclopramide as a palliative agent and a source of serious side effects necessitates careful consideration in treatment planning [Data: Entities (122), Relationships (273, 334, 335, +more)].\n\n## Nicotine's impact on dependence and side effects\n\nNicotine is primarily known for its role in palliation of nicotine dependence, but it also carries various side effects, including anxiety, angioedema, and arthritis. The compound's association with both therapeutic and adverse effects highlights the complexity of managing nicotine use in patients, particularly those with underlying health conditions. This duality necessitates a comprehensive approach to treatment and monitoring [Data: Entities (492), Relationships (827, 151, 447, +more)].\n\n## Common side effects across compounds\n\nSeveral compounds in this community share common side effects, such as anxiety, abdominal pain, and anaphylactic shock. This overlap indicates a need for heightened awareness among healthcare providers regarding the potential for adverse reactions when prescribing these medications. Understanding the shared side effects can aid in better patient management and risk assessment [Data: Entities (344, 484, 452, 122, 492), Relationships (360, 93, 111, 102, +more)].\"\n\n\n-----Entities-----\nhuman_readable_id,title,description,degree\n23,CLONIDINE,\"Clonidine is an adrenergic alpha2-agonist that is utilized in the management of various conditions. It has been shown to palliate symptoms associated with Attention Deficit Hyperactivity Disorder (ADHD), Restless Legs Syndrome, and Gilles De La Tourette Syndrome. While Clonidine can be effective in alleviating these symptoms, it is important to note that its use may be accompanied by various side effects.\",15\n29,GABAPENTIN,\"Gabapentin is a compound utilized in the treatment of Restless Legs Syndrome. It is classified under a pharmacologic category that works to decrease disorganized electrical activity in the central nervous system. This medication is effective in alleviating the symptoms associated with Restless Legs Syndrome; however, it is also linked to various side effects.\",15\n186,GILLES DE LA TOURETTE SYNDROME,Gilles De La Tourette Syndrome is a neurological disorder characterized by involuntary tics and other symptoms affecting the nervous system.,26\n187,AEROPHAGY,\"Aerophagy is a symptom associated with Gilles De La Tourette Syndrome, characterized by excessive swallowing of air.\",1\n200,AUTONOMIC NERVOUS SYSTEM,\"The autonomic nervous system is a part of the nervous system where Gilles De La Tourette Syndrome localizes, regulating involuntary bodily functions.\",1\n188,CATALEPSY,\"Catalepsy is a symptom associated with Gilles De La Tourette Syndrome, involving a trance-like state and muscular rigidity.\",1\n199,CEREBELLAR NUCLEAR COMPLEX,\"The cerebellar nuclear complex is a brain structure where Gilles De La Tourette Syndrome localizes, involved in coordination and balance.\",1\n189,CHOREA,\"Chorea is a symptom associated with Gilles De La Tourette Syndrome, characterized by irregular, unintentional movements.\",1\n190,\"DYKINESIA, DRUG-INDUCED\",\"Drug-induced dyskinesia is a symptom associated with Gilles De La Tourette Syndrome, resulting from medication side effects.\",1\n191,DYSTONIA,\"Dystonia is a symptom associated with Gilles De La Tourette Syndrome, involving involuntary muscle contractions.\",1\n192,ECHOLALIA,\"Echolalia is a symptom associated with Gilles De La Tourette Syndrome, characterized by the involuntary repetition of phrases or words.\",1\n193,HUNTINGTON DISEASE,Huntington Disease is a neurological disorder that can present symptoms similar to those of Gilles De La Tourette Syndrome.,1\n194,HYPERKINESIS,\"Hyperkinesis is a symptom associated with Gilles De La Tourette Syndrome, characterized by excessive movement.\",1\n195,LANGUAGE DISORDERS,\"Language disorders are symptoms associated with Gilles De La Tourette Syndrome, affecting communication abilities.\",1\n196,LEARNING DISORDERS,\"Learning disorders are symptoms associated with Gilles De La Tourette Syndrome, impacting educational performance.\",1\n197,INTERNAL CAPSULE OF TELENCEPHALON,\"The internal capsule of the telencephalon is a brain structure where Gilles De La Tourette Syndrome localizes, involved in motor control.\",1\n202,OLANZAPINE,\"Olanzapine is a compound used to palliate symptoms of Gilles De La Tourette Syndrome, with unspecified side effects.\",1\n203,MECAMYLAMINE,\"Mecamylamine is a compound used to palliate symptoms of Gilles De La Tourette Syndrome, with various side effects.\",1\n493,VARENICLINE,Varenicline is a partial cholinergic nicotinic agonist that treats Nicotine Dependence and has its own side effects.,8\n31,AGGRESSION,\"Aggression is a behavior characterized by hostile or violent actions or attitudes towards others. It is recognized as a potential side effect associated with several compounds used to palliate various medical conditions. Specifically, aggression can manifest as a side effect of treatments for Gilles De La Tourette Syndrome, where it is linked to certain medications. Additionally, the compound Varenicline has been noted to cause aggression as a side effect. Furthermore, aggression may also occur with various compounds used to alleviate symptoms of Prostate Cancer, as well as with the use of Gabapentin. Overall, aggression is an important behavioral consideration in the context of these medical treatments.\",4\n38,ANGER,\"Anger is a potential side effect associated with the use of certain medications, specifically Gabapentin and Varenicline. In the context of Gabapentin treatment, patients may experience anger as a side effect. Similarly, Varenicline, a compound used primarily for smoking cessation, is also linked to anger as a side effect. Thus, both medications have been noted to potentially induce feelings of anger in some individuals undergoing treatment.\",2\n32,AIRWAY OBSTRUCTION NOS,Airway obstruction NOS is a potential side effect of Gabapentin treatment.,1\n33,ALCOHOL INTOXICATION,Alcohol intoxication is listed as a side effect that may be associated with Gabapentin.,1\n139,ASTHMA,\"Asthma is a chronic respiratory condition characterized by difficulty in breathing, which results from inflammation and narrowing of the airways. It can be a potential side effect associated with several compounds used to palliate Gilles De La Tourette Syndrome, as well as with various treatments aimed at alleviating symptoms of Prostate Cancer.\",1\n212,FIBROSIS,\"Fibrosis is a potential side effect associated with several compounds used to palliate Gilles De La Tourette Syndrome, characterized by the thickening and scarring of connective tissue.\",1\n213,GLOSSITIS,\"Glossitis is a potential side effect associated with several compounds used to palliate Gilles De La Tourette Syndrome, characterized by inflammation of the tongue.\",1\n214,ORTHOSTATIC HYPOTENSION,\"Orthostatic hypotension is a potential side effect associated with several compounds used to palliate Gilles De La Tourette Syndrome, characterized by a sudden drop in blood pressure upon standing.\",1\n30,SIDE EFFECTS,\"Side effects associated with Gabapentin include abdominal pain, aggression, airway obstruction, and several others.\",1\n144,PANCREATITIS ACUTE,\"Acute Pancreatitis is a condition that can arise as a side effect associated with the compound Varenicline. Additionally, it is also recognized as a potential side effect of various compounds utilized in the palliative treatment of Prostate Cancer.\",2\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\n67,CLONIDINE,ATTENTION DEFICIT HYPERACTIVITY DISORDER,Clonidine can palliate Attention Deficit Hyperactivity Disorder,44\n22,RESTLESS LEGS SYNDROME,CLONIDINE,Clonidine is used to palliate symptoms of Restless Legs Syndrome,44\n28,RESTLESS LEGS SYNDROME,GABAPENTIN,\"Gabapentin is a medication that is utilized to alleviate the symptoms associated with Restless Legs Syndrome. It serves as a palliative treatment, helping to manage the discomfort and restlessness experienced by individuals suffering from this condition.\",44\n54,CLONIDINE,GILLES DE LA TOURETTE SYNDROME,Clonidine is used to palliate symptoms of Gilles De La Tourette Syndrome,41\n499,GILLES DE LA TOURETTE SYNDROME,PIMOZIDE,Pimozide is used to palliate symptoms of Gilles De La Tourette Syndrome,37\n502,GILLES DE LA TOURETTE SYNDROME,RISPERIDONE,Risperidone is used to palliate symptoms of Gilles De La Tourette Syndrome,37\n503,GILLES DE LA TOURETTE SYNDROME,PERPHENAZINE,Perphenazine is used to palliate symptoms of Gilles De La Tourette Syndrome,37\n504,GILLES DE LA TOURETTE SYNDROME,PERGOLIDE,Pergolide is used to palliate symptoms of Gilles De La Tourette Syndrome,37\n213,HALOPERIDOL,GILLES DE LA TOURETTE SYNDROME,Haloperidol is used to palliate symptoms of Gilles De La Tourette Syndrome,35\n55,CLONIDINE,ABDOMINAL PAIN,Abdominal pain is a potential side effect of Clonidine,34\n69,GABAPENTIN,ABDOMINAL PAIN,Abdominal pain is a side effect that may occur with the use of Gabapentin,34\n505,GILLES DE LA TOURETTE SYNDROME,ZIPRASIDONE,Ziprasidone is used to palliate symptoms of Gilles De La Tourette Syndrome,34\n35,BRAIN,GILLES DE LA TOURETTE SYNDROME,Gilles De La Tourette Syndrome localizes at the brain,33\n43,NERVOUS SYSTEM,GILLES DE LA TOURETTE SYNDROME,Gilles De La Tourette Syndrome localizes at the nervous system,32\n47,CENTRAL NERVOUS SYSTEM,GILLES DE LA TOURETTE SYNDROME,Gilles De La Tourette Syndrome localizes at the central nervous system,32\n496,GILLES DE LA TOURETTE SYNDROME,MIDBRAIN,Gilles De La Tourette Syndrome localizes at the midbrain,28\n485,GILLES DE LA TOURETTE SYNDROME,AEROPHAGY,Aerophagy is a symptom presented by Gilles De La Tourette Syndrome,27\n498,GILLES DE LA TOURETTE SYNDROME,AUTONOMIC NERVOUS SYSTEM,Gilles De La Tourette Syndrome localizes at the autonomic nervous system,27\n486,GILLES DE LA TOURETTE SYNDROME,CATALEPSY,Catalepsy is a symptom presented by Gilles De La Tourette Syndrome,27\n497,GILLES DE LA TOURETTE SYNDROME,CEREBELLAR NUCLEAR COMPLEX,Gilles De La Tourette Syndrome localizes at the cerebellar nuclear complex,27\n487,GILLES DE LA TOURETTE SYNDROME,CHOREA,Chorea is a symptom presented by Gilles De La Tourette Syndrome,27\n488,GILLES DE LA TOURETTE SYNDROME,\"DYKINESIA, DRUG-INDUCED\",Drug-induced dyskinesia is a symptom presented by Gilles De La Tourette Syndrome,27\n489,GILLES DE LA TOURETTE SYNDROME,DYSTONIA,Dystonia is a symptom presented by Gilles De La Tourette Syndrome,27\n490,GILLES DE LA TOURETTE SYNDROME,ECHOLALIA,Echolalia is a symptom presented by Gilles De La Tourette Syndrome,27\n491,GILLES DE LA TOURETTE SYNDROME,HUNTINGTON DISEASE,Huntington Disease can present symptoms similar to those of Gilles De La Tourette Syndrome,27\n492,GILLES DE LA TOURETTE SYNDROME,HYPERKINESIS,Hyperkinesis is a symptom presented by Gilles De La Tourette Syndrome,27\n493,GILLES DE LA TOURETTE SYNDROME,LANGUAGE DISORDERS,Language disorders are symptoms presented by Gilles De La Tourette Syndrome,27\n494,GILLES DE LA TOURETTE SYNDROME,LEARNING DISORDERS,Learning disorders are symptoms presented by Gilles De La Tourette Syndrome,27\n495,GILLES DE LA TOURETTE SYNDROME,INTERNAL CAPSULE OF TELENCEPHALON,Gilles De La Tourette Syndrome localizes at the internal capsule of telencephalon,27\n500,GILLES DE LA TOURETTE SYNDROME,OLANZAPINE,Olanzapine is used to palliate symptoms of Gilles De La Tourette Syndrome,27\n501,GILLES DE LA TOURETTE SYNDROME,MECAMYLAMINE,Mecamylamine is used to palliate symptoms of Gilles De La Tourette Syndrome,27\n76,GABAPENTIN,ANAEMIA,Anaemia is a side effect that may be associated with the use of Gabapentin,26\n80,GABAPENTIN,AMENORRHOEA,Amenorrhoea is a potential side effect of Gabapentin treatment,25\n828,NICOTINE DEPENDENCE,VARENICLINE,Varenicline treats Nicotine Dependence,24\n74,GABAPENTIN,AMNESIA,Amnesia is a side effect that may be experienced by patients taking Gabapentin,23\n75,GABAPENTIN,ANAPHYLACTIC SHOCK,Anaphylactic shock is a severe side effect that can occur with Gabapentin usage,23\n57,CLONIDINE,ALOPECIA,Alopecia is a potential side effect of Clonidine,22\n59,CLONIDINE,ANXIETY,Anxiety is a potential side effect of Clonidine,22\n73,GABAPENTIN,ALOPECIA,Alopecia is a side effect that can occur with the use of Gabapentin,22\n58,CLONIDINE,ANGIOEDEMA,Angioedema is a potential side effect of Clonidine,21\n78,GABAPENTIN,ANGIOEDEMA,Angioedema is a side effect that can occur with the use of Gabapentin,21\n81,GABAPENTIN,ANGINA PECTORIS,Angina pectoris is a side effect that may occur with the use of Gabapentin,21\n60,CLONIDINE,ARRHYTHMIA,Arrhythmia is a potential side effect of Clonidine,20\n391,ANOREXIA,VARENICLINE,Anorexia is a side effect of Varenicline,20\n56,CLONIDINE,AGGRESSION,Aggression is a potential side effect of Clonidine,19\n70,GABAPENTIN,AGGRESSION,Aggression is a side effect that may occur with the use of Gabapentin,19\n61,CLONIDINE,ARTHRALGIA,Arthralgia is a potential side effect of Clonidine,19\n79,GABAPENTIN,AMBLYOPIA,Amblyopia is a side effect that may be associated with Gabapentin,19\n112,ANAEMIA,VARENICLINE,Anaemia is a side effect of Varenicline,19\n77,GABAPENTIN,ANGER,Anger is a potential side effect of Gabapentin treatment,17\n63,CLONIDINE,FATIGUE,Fatigue is a potential side effect of Clonidine,17\n402,ABDOMINAL DISTENSION,VARENICLINE,Abdominal Distension is a side effect of Varenicline,17\n71,GABAPENTIN,AIRWAY OBSTRUCTION NOS,Airway obstruction NOS is a potential side effect of Gabapentin,16\n72,GABAPENTIN,ALCOHOL INTOXICATION,Alcohol intoxication is a side effect that may be associated with Gabapentin,16\n62,CLONIDINE,ASTHMA,Asthma is a potential side effect of Clonidine,16\n64,CLONIDINE,FIBROSIS,Fibrosis is a potential side effect of Clonidine,16\n65,CLONIDINE,GLOSSITIS,Glossitis is a potential side effect of Clonidine,16\n66,CLONIDINE,ORTHOSTATIC HYPOTENSION,Orthostatic hypotension is a potential side effect of Clonidine,16\n68,GABAPENTIN,SIDE EFFECTS,\"Gabapentin has various side effects, including abdominal pain and aggression\",16\n134,ANGINA PECTORIS,VARENICLINE,Angina Pectoris is a side effect of Varenicline,14\n83,AGGRESSION,VARENICLINE,Aggression is a side effect of Varenicline,12\n82,AGGRESSION,ESOMEPRAZOLE,Esomeprazole can cause aggression as a side effect,10\n113,ANGER,VARENICLINE,Anger is a side effect of Varenicline,10\n379,PANCREATITIS ACUTE,VARENICLINE,Acute Pancreatitis is a side effect of Varenicline,10\n338,HYDROCORTISONE,PANCREATITIS ACUTE,Hydrocortisone can cause pancreatitis acute as a side effect,7\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}